(Press-News.org) European researchers have recovered a genome of the bacterium Brucella melitensis from a 700-year-old skeleton found in the ruins of a Medieval Italian village.
Reporting this week in mBio®, the online open-access journal of the American Society for Microbiology, the authors describe using a technique called shotgun metagenomics to sequence DNA from a calcified nodule in the pelvic region of a middle-aged male skeleton excavated from the settlement of Geridu in Sardinia, an island off the coast of Italy. Geridu is thought to have been abandoned in the late 14th century. Shotgun metagenomics allows scientists to sequence DNA without looking for a specific target.
From this sample, the researchers recovered the genome of Brucella melitensis, which causes an infection called brucellosis in livestock and humans. In humans, brucellosis is usually acquired by ingesting unpasteurized dairy products or from direct contact with infected animals. Symptoms include fevers, arthritis and swelling of the heart and liver. The disease is still found in the Mediterranean region.
"Normally when you think of calcified material in human or animal remains you think about tuberculosis, because that's the most common infection that leads to calcification," says senior study author Mark Pallen, PhD, professor of microbial genomics at Warwick Medical School in Coventry, England. "We were a bit surprised to get Brucella instead."
The skeleton contained 32 hardened nodules the size of a penny in the pelvic area, though Pallen says it's unclear if they originated in the pelvis, or higher up in the chest or other body part.
In additional experiments, the research team showed that the DNA fragments extracted had the appearance of aged DNA – they were shorter than contemporary strands, and had characteristic mutations at the ends. They also found that the medieval Brucella strain, which they called Geridu-1, was closely related to a recent Brucella strain called Ether, identified in Italy in 1961, and two other Italian strains identified in 2006 and 2007.
Pallen and others have used shotgun metagenomics before to detect pathogens in contemporary and historical human material. Last summer, he published a report in the New England Journal of Medicine describing the recovery of tuberculosis genomes from the lung tissue of a 215-year-old mummy from Hungary. He also has identified Eschericia coli from stool samples during a 2011 outbreak in Germany.
Pallen's team is now testing the technique on a range of additional samples, including historical material from Hungarian mummies; Egyptian mummies; a Korean mummy from the 16th or 17th century; and lung tissue from a French queen from the Merovingian dynasty, which ruled France from the 5th to 8th centuries; as well as contemporary sputum samples from the Gambia in Africa.
"Metagenomics stands ready to document past and present infections, shedding light on the emergence, evolution and spread of microbial pathogens," Pallen says. "We're cranking through all of these samples and we're hopeful that we're going to find new things."
INFORMATION:
The study was supported by the Sardinia Region and Warwick Medical School.
mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://mbio.asm.org.
The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.
Little too late: Researchers identify disease that may have plagued 700-year-old skeleton
2014-07-15
ELSE PRESS RELEASES FROM THIS DATE:
Study reveals how gardens could help dementia care
2014-07-15
A new study has revealed that gardens in care homes could provide promising therapeutic benefits for patients suffering from dementia.
The research is published in the Journal of the American Medical Directors Association and by critically reviewing the findings from 17 different pieces of research, has found that outdoor spaces can offer environments that promote relaxation, encourage activity and reduce residents' agitation.
Conducted by a team at the University of Exeter Medical School and supported by the National Institute for Health Research Collaboration for ...
Fungicides for crops: Worrying link to fungal drug resistance in UK warns scientists
2014-07-15
Crop spraying on British farms could be aiding a life-threatening fungus suffered by tens of thousand of people in the UK each year.
New research by British and Dutch scientists has found that Aspergillus – a common fungus that attacks the lungs and is found in soil and other organic matter – has become resistant to life - saving drugs in parts of rural Yorkshire.
It's the first time a link has been made in the UK between drug resistance in Aspergillus and fungicide used on crops. Experts warn their findings, now published, are significant and raise serious implications ...
Pre-diabetes label 'unhelpful and unnecessary'
2014-07-15
Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.
The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes by a few years, and found no evidence of long-term health benefits.
Type 2 diabetes is typically diagnosed ...
Reduced range of facial expression indicates serious heart/lung disease
2014-07-15
Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal.
This finding could be used to help busy emergency care doctors decide whom to prioritise for treatment, and gauge who really needs often costly and invasive tests, suggest the researchers.
And it adds scientific credibility to the rapid visual assessment doctors make of how sick someone is, formally known as gestalt pretest ...
Patients with advanced co-existing illnesses and their carers face uphill struggle
2014-07-15
Patients in their last year of life with co-existing illnesses struggle to cope with a bewildering array of services and treatments, which are often poorly coordinated and lack any continuity of care, indicates an analysis of patient and carer feedback, published online in BMJ Supportive & Palliative Care.
Patients and carers frequently found accessing the support they needed "impersonal" and "challenging," the comments showed.
It's important to get this right, say the researchers, because 'multimorbidity,' in which patients are coping with several illnesses at the ...
Annals of Internal Medicine tip sheet for July 15, 2014, issue
2014-07-15
1. Pill appearance affects how patients take their medications*
*Sound bites and b-roll footage available. See bottom of page for feed dates, times, and coordinates
Heart patients significantly more likely to stop taking medication after pill changes appearance
When it comes to taking generic heart medications, appearance matters, according to a study published in Annals of Internal Medicine (http://www.annals.org/article.aspx?doi=10.7326/M13-2381). Physicians often prescribe generic medications for the treatment of cardiovascular disease because generics are inexpensive ...
Changes in generic pill color and shape disrupt use
2014-07-15
Boston, MA—Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, and the shape and color of patients' pills may vary based on the particular supply at the patient's pharmacy. Studying a national cohort of patients who recently suffered a heart attack, researchers from Brigham and Women's Hospital (BWH) have found that variation in appearance of generic drugs is associated with a greater risk of patients ...
Bonuses for doctors do little to improve cancer screening in Ontario
2014-07-15
TORONTO, July 14, 2014 – Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES).
The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and colorectal cancer in Ontario each year between 2000 and 2010. Researchers found no significant ...
July/August 2014 Annals of Family Medicine tip sheet
2014-07-15
High Prevalence of Unsafe All-Terrain Vehicle Ridership Among Adolescents in Iowa
More youth are killed every year in the United States in all-terrain vehicle crashes than on bicycles, and since 2001, one-fifth of all ATV fatalities have involved victims aged 15 years or younger. To better understand ATV riding practices among adolescents, researchers surveyed 4,684 youths aged 11 to 16 years at 30 schools across Iowa and found the vast majority reported having ridden an ATV, and most practiced unsafe riding behaviors and had experienced at least one crash. Specifically, ...
New combination drug controls tumor growth and metastasis in mice
2014-07-15
SACRAMENTO, Calif. — Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences.
"We've been studying the effects of COX and sEH inhibitors, both by themselves and in combination, for several ...